D.E. Shaw & Co’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-238,233
| Closed | -$976K | – | 4658 |
|
|
2022
Q1 | $976K | Buy |
+238,233
| New | +$976K | ﹤0.01% | 2889 |
|
|
2021
Q1 | – | Sell |
-68,395
| Closed | -$273K | – | 3294 |
|
|
2020
Q4 | $273K | Buy |
68,395
+55,780
| +442% | +$223K | ﹤0.01% | 2483 |
|
|
2020
Q3 | $34K | Sell |
12,615
-45,065
| -78% | -$121K | ﹤0.01% | 2529 |
|
|
2020
Q2 | $158K | Buy |
57,680
+16,566
| +40% | +$45.4K | ﹤0.01% | 2495 |
|
|
2020
Q1 | $97K | Buy |
41,114
+5,147
| +14% | +$12.1K | ﹤0.01% | 2555 |
|
|
2019
Q4 | $169K | Buy |
+35,967
| New | +$169K | ﹤0.01% | 2534 |
|
|
2018
Q3 | – | Sell |
-30,211
| Closed | -$78K | – | 2793 |
|
|
2018
Q2 | $78K | Buy |
+30,211
| New | +$78K | ﹤0.01% | 2511 |
|
|
2017
Q2 | – | Sell |
-197,653
| Closed | -$561K | – | 2630 |
|
|
2017
Q1 | $561K | Sell |
197,653
-137,564
| -41% | -$390K | ﹤0.01% | 1949 |
|
|
2016
Q4 | $781K | Buy |
335,217
+138,768
| +71% | +$323K | ﹤0.01% | 1859 |
|
|
2016
Q3 | $330K | Buy |
196,449
+86,605
| +79% | +$145K | ﹤0.01% | 2169 |
|
|
2016
Q2 | $115K | Sell |
109,844
-41,805
| -28% | -$43.8K | ﹤0.01% | 2428 |
|
|
2016
Q1 | $132K | Sell |
151,649
-25,497
| -14% | -$22.2K | ﹤0.01% | 2449 |
|
|
2015
Q4 | $214K | Buy |
177,146
+106,723
| +152% | +$129K | ﹤0.01% | 2405 |
|
|
2015
Q3 | $120K | Sell |
70,423
-82,914
| -54% | -$141K | ﹤0.01% | 2431 |
|
|
2015
Q2 | $319K | Buy |
153,337
+18,828
| +14% | +$39.2K | ﹤0.01% | 2314 |
|
|
2015
Q1 | $365K | Buy |
134,509
+28,511
| +27% | +$77.4K | ﹤0.01% | 2188 |
|
|
2014
Q4 | $272K | Buy |
+105,998
| New | +$272K | ﹤0.01% | 2243 |
|
|
2013
Q4 | – | Sell |
-11,809
| Closed | -$48K | – | 2685 |
|
|
2013
Q3 | $48K | Buy |
+11,809
| New | +$48K | ﹤0.01% | 2337 |
|